Closes 20 January 2027
Cell and Gene Therapy for Personalised Medicine (CGT4PM2027)
European Partnership for Personalised Medicine (Horizon Europe)
- How much
- Up to €37,000,000 in total for this call
- Closing date
- 20 January 2027
- Opens
- 4 November 2026
- Where
- UK-wide
- Total fund
- HORIZON-HLTH-2023-CARE-08-01
- Who can apply
- Private Sector, Non-profit, Public Sector
- Aimed at
- Any sector
Cell and Gene Therapy for Personalised Medicine (CGT4PM2027)
About the grant
With this JTC, EP PerMed will fund research projects in human health on Cell and Gene Therapies (CGT) for PM approaches. Proposals must focus on the development and validation of an innovative and novel CGT for PM. At least one of the following approaches must be employed: Somatic cell therapeutics ; Gene therapeutics ; Combined cell- and gene therapeutics ; Novel biological products. For the entire scope, please consult the Call Text: https://www.eppermed.eu/funding-projects/calls/jtc2027/ .
Who can apply
All information and documents concerning the EP PerMed Joint Transnational Call (JTC) 2027, including the call text outlining the aims and scope of the call, the Guidelines for Applicants document, the pre-proposal form, etc. can be found here: https://www.eppermed.eu/funding-projects/calls/jtc2027/ . Electronic submission system: https://ptoutline.eu/app/eppermed2027 . Deadline to submit pre-proposals: 20 January 2027 (14:00, CET) Deadline to submit full proposals: 25 May 2027 (14:00, CEST)
How to apply
Apply through the EU Funding & Tenders portal. UK organisations can take part in Horizon Europe on the same terms as EU members. Many calls need a group of partners from different countries.
Taken from the funder's website. Last updated 7 November 2026.